The Korean Journal of Parasitology (KJP)

Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency

Huaie Liu, Weilin Zeng, Pallavi Malla, Chengqi Wang, Seetha Lakshmi, Kami Kim, Lynette Menezes, Zhaoqing Yang, Liwang Cui

Plasmodium cynomolgi in humans: current knowledge and future directions of an emerging zoonotic malaria parasite

Loick P. Kojom Foko, Amit Kumar, Joseph Hawadak, Vineeta Singh

The medication for pneumocystis pneumonia with glucose-6-phosphate dehydrogenase deficiency patients

Ziyu Zhang, Qinhui Li, Xiaoyan Shen, Lankai Liao, Xia Wang, Min Song, Xi Zheng, Yulian Zhu, Yong Yang

G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs

Targeting Gametocytes of the Malaria Parasite Plasmodium falciparum in a Functional Genomics Era: Next Steps

Recent Advances in Transmission-Blocking Drugs for Malaria Elimination

Ishan Wadi, Mahendra Nath, Anupkumar R Anvikar, Pargat Singh, Abhinav Sinha

Future Medicinal Chemistry.2019; 11(23): 3047. CrossRef

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients

Sara Avalos, Rosa E. Mejia, Engels Banegas, Cesar Salinas, Lester Gutierrez, Marcela Fajardo, Suzeth Galo, Alejandra Pinto, Angel Mejia, Gustavo Fontecha

A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications

European Journal of Drug Metabolism and Pharmacokinetics.2017; 42(5): 745. CrossRef

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies

Olalekan A. Uthman, Patricia M. Graves, Rachel Saunders, Hellen Gelband, Marty Richardson, Paul Garner

Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond

Ken Ing Cherng Ong, Hodaka Kosugi, Sophea Thoeun, Hitomi Araki, Moe Moe Thandar, Moritoshi Iwagami, Bouasy Hongvanthong, Paul T Brey, Shigeyuki Kano, Masamine Jimba

Evaluation of Efficacy of Chloroquine for Plasmodium Vivax Infection Using Parasite Clearance Times: A 10-Year Study and Systematic Review

Hariharan Subramony, Noppadon Tangpukdee, Srivicha Krudsood, Kittiyod Poovorawan, Sant Muangnoicharoen, Polrat Wilairatana

Annals of the Academy of Medicine, Singapore.2016; 45(7): 303. CrossRef

Enantioselective Pharmacokinetics of Primaquine in Healthy Human Volunteers

Babu L Tekwani, Bharathi Avula, Rajnish Sahu, Narayan D Chaurasiya, Shabana I Khan, Surendra Jain, Pius S Fasinu, H.M.T. Bandara Herath, Donald Stanford, N.P. Dhammika Nanayakkara, James D McChesney, Travis W Yates, Mahmoud A ElSohly, Ikhlas A Khan, Larry

Drug Metabolism and Disposition.2015; 43(4): 571. CrossRef

Cátia Teixeira, Nuno Vale, Bianca Pérez, Ana Gomes, José R. B. Gomes, Paula Gomes

KAI407, a Potent Non-8-Aminoquinoline Compound That Kills Plasmodium cynomolgi Early Dormant Liver Stage ParasitesIn Vitro

Anne-Marie Zeeman, Sandra M. van Amsterdam, Case W. McNamara, Annemarie Voorberg-van der Wel, Els J. Klooster, Alexander van den Berg, Edmond J. Remarque, David M. Plouffe, Geert-Jan van Gemert, Adrian Luty, Robert Sauerwein, Kerstin Gagaring, Rachel Borb

Antimicrobial Agents and Chemotherapy.2014; 58(3): 1586. CrossRef

Novel approaches in antimalarial drug discovery

Jana Held, Andrea Kreidenweiss, Benjamin Mordmüller

Expert Opinion on Drug Discovery.2013; 8(11): 1325. CrossRef

Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine

Gawrie NL Galappaththy, Prathap Tharyan, Richard Kirubakaran

Cochrane Database of Systematic Reviews.2013;[Epub] CrossRef

Effects of Antimalarial Molecules on the Gametocyte Stage of Plasmodium falciparum: The Debate

Journal of Medicinal Chemistry.2012; 55(23): 10328. CrossRef

Targeting the Liver Stage of Malaria Parasites: A Yet Unmet Goal

Tiago Rodrigues, Miguel Prudêncio, Rui Moreira, Maria M. Mota, Francisca Lopes

Journal of Medicinal Chemistry.2012; 55(3): 995. CrossRef

Ellen M. McDonagh, Caroline F. Thorn, José M. Bautista, Ilan Youngster, Russ B. Altman, Teri E. Klein

Pharmacogenetics and Genomics.2012; 22(3): 219. CrossRef

New approaches in antimalarial drug discovery and development: a review

Anna Caroline C Aguiar, Eliana MM da Rocha, Nicolli B de Souza, Tanos CC França, Antoniana U Krettli

Memórias do Instituto Oswaldo Cruz.2012; 107(7): 831. CrossRef

Ric N. Price, Nicholas M. Douglas, Nicholas M. Anstey, Lorenz von Seidlein

Current Opinion in Infectious Diseases.2011; 24(6): 578. CrossRef

Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination

Timothy N.C. Wells, Jeremy N. Burrows, J. Kevin Baird

Trends in Parasitology.2010; 26(3): 145. CrossRef

Blocking Plasmodium falciparum Malaria Transmission with Drugs: The Gametocytocidal and Sporontocidal Properties of Current and Prospective Antimalarials

Medications and Glucose-6-Phosphate Dehydrogenase Deficiency

Ilan Youngster, Lidia Arcavi, Renata Schechmaster, Yulia Akayzen, Hen Popliski, Janna Shimonov, Svetlana Beig, Matitiahu Berkovitch

A pre-emptive strike against malaria's stealthy hepatic forms

Nature Reviews Drug Discovery.2009; 8(11): 854. CrossRef

Resistance to Therapies for Infection byPlasmodium vivax

Clinical Microbiology Reviews.2009; 22(3): 508. CrossRef

8-Aminoquinolines: future role as antiprotozoal drugs

Current Opinion in Infectious Diseases.2006; 19(6): 623. CrossRef